APA

van den Bergh M. R., Spijkerman J., François N., Swinnen K., Borys D., Schuerman L., Veenhoven R. H. & Sanders E. A. M. (20111207). Immunogenicity, safety, and reactogenicity of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine and DTPa-IPV-Hib when coadministered as a 3-dose primary vaccination schedule in The Netherlands: a randomized controlled trial. : The Pediatric infectious disease journal.

Chicago

van den Bergh Menno R, Spijkerman Judith, François Nancy, Swinnen Kristien, Borys Dorota, Schuerman Lode, Veenhoven Reinier H and Sanders Elisabeth A M. 20111207. Immunogenicity, safety, and reactogenicity of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine and DTPa-IPV-Hib when coadministered as a 3-dose primary vaccination schedule in The Netherlands: a randomized controlled trial. : The Pediatric infectious disease journal.

Harvard

van den Bergh M. R., Spijkerman J., François N., Swinnen K., Borys D., Schuerman L., Veenhoven R. H. and Sanders E. A. M. (20111207). Immunogenicity, safety, and reactogenicity of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine and DTPa-IPV-Hib when coadministered as a 3-dose primary vaccination schedule in The Netherlands: a randomized controlled trial. : The Pediatric infectious disease journal.

MLA

van den Bergh Menno R, Spijkerman Judith, François Nancy, Swinnen Kristien, Borys Dorota, Schuerman Lode, Veenhoven Reinier H and Sanders Elisabeth A M. Immunogenicity, safety, and reactogenicity of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine and DTPa-IPV-Hib when coadministered as a 3-dose primary vaccination schedule in The Netherlands: a randomized controlled trial. : The Pediatric infectious disease journal. 20111207.